Joseph Edelman – AMLX history
- Issuer:
- AMYLYX PHARMACEUTICALS INC
- Quarters tracked:
- 17 (Q1 2022 → Q1 2026)
- Current shares:
- 8,284,882
- Current value:
- $115.16M
- Peak shares:
- 8,952,365 (Q3 2025)
- Overall change:
- +462%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 8,284,882 | $115.16M | $13.90 | 0 | 0% |
| Q4 2025 | 8,284,882 | $100.08M | $12.08 | -667,483 | -7% |
| Q3 2025 | 8,952,365 | $121.66M | $13.59 | +1,050,000 | +13% |
| Q2 2025 | 7,902,365 | $50.65M | $6.41 | +28,017 | 0% |
| Q1 2025 | 7,874,348 | $27.88M | $3.54 | +1,100,000 | +16% |
| Q4 2024 | 6,774,348 | $25.61M | $3.78 | +4,648,699 | +219% |
| Q3 2024 | 2,125,649 | $6.89M | $3.24 | +2,125,649 | +100% |
| Q2 2024 | SOLD | — | — | -300,000 | -100% |
| Q1 2024 | 300,000 | $852K | $2.84 | -1,569,125 | -84% |
| Q4 2023 | 1,869,125 | $27.51M | $14.72 | -819,748 | -30% |
| Q3 2023 | 2,688,873 | $49.23M | $18.31 | -2,185,046 | -45% |
| Q2 2023 | 4,873,919 | $105.13M | $21.57 | -1,160,725 | -19% |
| Q1 2023 | 6,034,644 | $177.06M | $29.34 | -53,689 | -1% |
| Q4 2022 | 6,088,333 | $224.96M | $36.95 | +616,300 | +11% |
| Q3 2022 | 5,472,033 | $154.04M | $28.15 | +1,931,625 | +55% |
| Q2 2022 | 3,540,408 | $68.19M | $19.26 | +2,066,301 | +140% |
| Q1 2022 | 1,474,107 | $18.94M | $12.85 | — | NEW |